Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Enovis CORPENOV · Entity 4797 | Director | May 19, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Enovis CORP
Report date May 19, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.001SEC Table I · non-derivative | Direct | 24,201 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 9,346 · Balance 24,201 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2026 Filed May 22, 2026 00:30 UTC | Enovis CORP ENOV · Entity 4797 | GrantCommon stock, par value $0.001 | 9,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-235175 · ownership.xml · nonDerivative · entry 1 Okala Philip · CIK 0001843147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,201 Read SEC document |
| May 21, 2025 Filed May 24, 2025 01:00 UTC | Enovis CORP ENOV · Entity 4797 | GrantCommon stock, par value $0.001 | 6,598 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077287 · ownership.xml · nonDerivative · entry 1 Okala Philip · CIK 0001843147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,855 Read SEC document |
| May 20, 2024 Filed May 23, 2024 00:00 UTC | Enovis CORP ENOV · Entity 4797 | GrantCommon stock, par value $0.001 | 4,338 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-063715 · ownership.xml · nonDerivative · entry 1 Okala Philip · CIK 0001843147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,257 Read SEC document |
| May 16, 2023 Filed May 18, 2023 23:00 UTC | Enovis CORP ENOV · Entity 4797 | GrantDirector stock option (right to buy) · Derivative | 4,167 | $0.00 Strike: $56.76 | $0.00 |
DisclosureSEC source: 0001209191-23-030810 · doc4.xml · derivative · entry 2 Okala Philip · CIK 0001843147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,167 Underlying: Common stock, par value $0.001 · 4,167 shares Expires 2030-05-16 Read SEC document |
| May 16, 2023 Filed May 18, 2023 23:00 UTC | Enovis CORP ENOV · Entity 4797 | GrantCommon stock, par value $0.001 | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030810 · doc4.xml · nonDerivative · entry 1 Okala Philip · CIK 0001843147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,029 Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 23:00 UTC | Enovis CORP ENOV · Entity 4797 | GrantDirect stock option (right to buy) · Derivative | 3,464 | $0.00 Strike: $67.28 | $0.00 |
DisclosureSEC source: 0001209191-22-035605 · doc4.xml · derivative · entry 2 Okala Philip · CIK 0001843147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,464 Underlying: Common stock, par value $.001 · 3,464 shares Expires 2029-06-07 Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 23:00 UTC | Enovis CORP ENOV · Entity 4797 | GrantCommon stock, par value $.001 | 1,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035605 · doc4.xml · nonDerivative · entry 1 Okala Philip · CIK 0001843147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,154 F1 · balance_after: Holdings reflect the adjustments that occurred as of April 4, 2022 in connection with the spin-off of ESAB Corporation by the Issuer. In connection with the spin-off, each outstanding restricted stock unit was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded down to the nearest whole unit. In addition, holdings have been updated to reflect the impact of the one-for-three reverse stock split effected by the Issuer on April 4, 2022. Read SEC document |
| May 12, 2021 Filed May 14, 2021 23:00 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 3,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032907 · doc4.xml · nonDerivative · entry 1 Okala Philip · CIK 0001843147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,651 Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:18 UTC | Enovis CORP CFX · Entity 4797 | GrantDirector Stock Option (right to buy) · Derivative | 878 | $0.00 Strike: $44.91 | $0.00 |
DisclosureSEC source: 0001209191-21-014045 · doc4.xml · derivative · entry 2 Okala Philip · CIK 0001843147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 878 Underlying: Common Stock, par value $.001 · 878 shares Expires 2028-02-21 Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:18 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon Stock, par value $.001 | 357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-014045 · doc4.xml · nonDerivative · entry 1 Okala Philip · CIK 0001843147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.